We have found that two alleles of the MET locus are rearranged in the human cell line MNNG-HOS. One allele is the previously characterized TPR-MET oncogene and the other is found on a der(7)t(1;7)(q23;q32) marker chromosome. These data and in situ chromosomal hybridization analysis would indicate that MET and, therefore, the cystic fibrosis locus are located at bands q31-q32 on human chromosome 7. Using somatic cell hybrids, we show that the chromosome containing the TPR-MET oncogene is grossly rearranged and contains both the upstream and downstream portions of the MET protooncogene locus. These results demonstrate that the TPR-MET oncogene rearrangement involving chromosomes 1 and 7 is either due to an insertion of TPR sequences into the MET locus or is more complex. We also show that the upstream MET protooncogene locus is deleted on der(7), while the downstream portion is retained. We cannot exclude that this is due to an interstitial chromosomal deletion or to a more complex rearrangement, but if MET maps at the breakpoint in der(7), then the 3' end of the MET transcription unit should be oriented towards the centromere. We also show that other DNA restriction fragment length polymorphism markers tightly linked with the inheritance of cystic fibrosis are deleted on der(7).
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Cystic fibrosis (CF) is the most common lethal genetically inherited disease in Caucasians. The basic genetic defect that causes CF is unknown, and although there are no apparent changes in chromosome structure associated with the disease that serve to localize its position, genetic linkage with the protein marker PON (1) and DNA restriction fragment length polymorphism (RFLP) probes from the MET locus (2, 3) , 917 (D7S15) (4) and pJ3.11 (D7S8) (5) , have allowed the mapping of the CF mutation of the long arm of chromosome 7. Data from a collaborative study of the recombination fraction between MET, pJ3.11, and the CF locus placed MET and pJ3.11 within 1 centimorgan of CF and provided evidence that these markers map to opposite sides of the CF locus (6, 7) . The combined linkage data using the additional chromosome 7 DNA markers, pro-a2-collagen (COLIA2) (8) and T-cell receptorB (TCRB) (9) , indicated a preferred order for CF and its flanking markers as 7cen-917-PON-MET-CF-pJ3.11-TCRP (6, 10) . To facilitate the cloning of the CF locus, it is important to determine the physical orientation of these markers on chromosome 7.
The MET oncogene (11) was activated in a human osteosarcoma cell line (HOS TE85 clone 5) (12) after treatment in vitro with the carcinogen N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) (13) . Activation of MET in MNNG-HOS cells resulted from a DNA rearrangement that fused sequences from the TPR (translocated promoter region) locus on chromosome 1 with the MET protooncogene locus on chromosome 7 (14, 15) . The TPR-MET oncogene locus from MNNG-HOS cells has been used as a selective marker in chromosome-mediated gene transfer experiments (16) to isolate a candidate CF gene (17) .
Karyotypic analysis of the parental HOS cell line and MNNG-HOS cells showed that both cell lines have highly complex hyperdiploid karyotypes: the modal chromosome number was 53 in HOS cells and 64 in MNNG-HOS cells (18) . Numerous structural alterations and aneuploidy were identified in all cells, but both cell lines contained marker chromosomes in common, indicating that the MNNG-HOS cell line was indeed derived from the HOS cell line. One marker found in all HOS and MNNG-HOS cells involved a rearrangement between chromosomes 1 and 7 [der(7)] (18) and was present in the earliest passage of HOS cells analyzed (12) . The der(7) is an unbalanced translocation derivative chromosome with breakpoints at bands 1q23 and 7q32 [der(7)t(1;7)(q23;q32)].
Since the TPR-MET oncogene activation involved sequences from chromosome 1 (TPR) and chromosome 7 (MET), we initially thought that der(7) served as the substrate for the MNNG-mediated oncogene activation. To study the structure of the MET locus on der(7), somatic cell hybrids were generated between MNNG-HOS cells and mouse NIH 3T3 cells. Analyses of these hybrid cells revealed that there are two independently rearranged MET alleles in MNNG-HOS cells, one in der(7) and the other in the TPR-MET oncogene. We show that the latter rearrangement is complex, while in der(7) the MET rearrangement may map at the translocation breakpoint. We have used these somatic cell hybrids to localize other DNA markers 
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The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. (19) and selected for resistance to the neomycin analog G418 (GIBCO; 400 ,g/ml). Drug 10 -cm dishes and 24 hr later cells were selected in media containing G418 at 400 ,g/ml and 0.1 uM ouabain. Control NIH 3T3 and MNNG-HOS (pGV16) cells were each sensitive to this selection protocol. Colonies were identified after 3 weeks, and 50 colonies were isolated by using cloning cylinders and grown initially in medium containing G418 alone for further analysis. Clones were subsequently maintained in normal media without selective agents and screened for morphological transformation and for chromosome 7 sequences by hybridization to a MET-specific probe (pmetl; Fig. 1) . Selected colonies were then cloned in 96-well microtiter plates and single-cell clones were selected for further analysis.
Southern Transfer and Hybridization. High molecular weight cellular DNA (10 ,ug) was digested with restriction endonucleases (Boehringer Mannheim), using the conditions recommended by the supplier. Samples were electrophoresed in 0.8% agarose gels and DNA was transferred from gels to nylon membranes (20) (BioTrace RP; Gelman). Probes were either nick-translated or random-primed by using standard procedures. Hybridization and washing conditions were as described (14) .
In Situ Hybridization. In situ hybridization was performed on chromosomes prepared from phytohemagglutinin-stimulated normal human male lymphocytes as described (21) . A pmetl (15) DNA probe was radiolabeled by nick-translation with 3H-labeled deoxyribonucleotides to a specific activity of 4.5 x 107 cpm/,Lg. Chromosome preparations were treated with RNase A (Sigma) at 100 mg/ml in 2 x SSC (1 x SSC = 0.15 M NaCl/0.015 M sodium citrate, pH 7.0) for 1 hr at 37°C and then denatured in 70% (vol/vol) formamide in 2 x SSC at 70°C for 2 min. Labeled probe was heated at 70°C for 5 min and then placed on slides at a concentration of 11-66 ng/ml in 50% formamide/2 x SSC/10% dextran sulfate (Sigma) with sonicated salmon sperm DNA at 500-fold excess included as carrier. Slides were placed in a humidified chamber at 37°C for 16 hr. After hybridization, the slides were washed in 50% formamide/2 x SSC at 39°C, followed by additional washing in 2 x SSC (39°C). Slides were dehydrated, dipped in NTB-2 nuclear track emulsion (Kodak), and (Fig. 1) . The 4.0-kb fragment occurs at the TPR-MET junction (14, 15) , whereas the larger 14.0-kb DNA fragment is homologous to MET sequences upstream from the TPR-MET breakpoint (data not shown). These data show that the type C hybrid cells contain the TPR-MET oncogene (Fig. 1) as well as portions of the MET locus upstream from the breakpoint. Karyotypically they lack chromosome 7 or der(7) ( (20) . The nylon filter was subjected to hybridization with the 32P-labeled pmetl probe, which spans the breakpoint of the TPR-MET oncogene (14, 15 (22) were used to analyze DNA from each somatic cell hybrid. A probe from the 3' end (MET 3', Fig. 2A) (14, 18) , detects a 1.1-kb EcoRI fragment in the DNA from types A, B, and C hybrids, demonstrating that the downstream portion of the MET locus is present in all three types (Fig. 2A) . The intensity of hybridization in types A and B hybrid cells is consistent with the chromosome 7 and der(7) copy numbers, respectively, as determined by karyotypic analysis (Table 1 ). Additional evidence demonstrating that MET protooncogene sequences upstream from the TPR-MET breakpoint are present in the type C hybrid was obtained by using a MET 5' probe (22, 23) that is approximately 100 kb upstream from the fragment detected by the MET 3' probe (18, 22) . The MET 5' probe detects the germ-line 3.7-kb EcoRI fragment in types A and C hybrid DNA (compare human placental DNA, Fig. 2A ). The results with pmetl ( Fig. 2A) as well as other MET protooncogene probes described below demonstrate that the MET locus upstream of the TPR-MET breakpoint is present in the type C hybrid cells. Sequences homologous to the MET 5' probe were not present at the expected level of intensity in the type B hybrid cell DNA and must, therefore, be deleted from der(7) (Fig.  2A) . The weak hybridization of this probe (as well as others described below) to hybrid B DNA is consistent with the presence of approximately one copy of chromosome 7 per 10 metaphase cells as determined by cytogenetic analysis (Table 1) . Three additional probes spanning 30 kb of DNA in the 5' portion of the MET genomic locus hybridized to DNA fragments in the germ-line configuration in both the type A and type C hybrids but failed to hybridize to type B hybrid DNA (data not shown). These analyses show that the 5' portion of the MET protooncogene locus is deleted in the type B hybrid.
Sublocalization of MET by in Situ Chromosomal Hybridization. The above analyses raise the possibility that MET is at the breakpoint in der(7). If so, MET can be localized to a position between the distal portion of band 7q31 and the proximal portion of 7q32. Previous in situ chromosomal hybridization studies mapped MET at 7q21-31 (3). To more precisely define the position of MET on chromosome 7, we performed additional in situ hybridization, using pmetl (15) to probe metaphase and prometaphase chromosomes of normal lymphocytes (Fig. 3B ) and lymphoblastoid cells (GM-7173) containing a congenital rearrangement, t(5;7)(q35;q22) (Fig. 3C) . Normal cells showed clustering of grains to 7q31-32 (Fig. 3B) . In the lymphoblastoid cell line there was significant labeling on the normal 7 and Sq +, confirming that MET is located distal to 7q22, with most grains clustered at 7q31 (Fig.  3C) .
Analysis of Hybrids with DNA Markers Linked to CF. To examine whether other DNA markers genetically linked to CF are present on der(7), we probed hybrid B DNA with the CF marker, pJ3.11, and two additional linked CF markers, 7C22 (24) and B79a (25) . Whereas probes pJ3.11, 7C22, and B79a all hybridize to type C hybrid DNA containing the TPR-MET oncogene (Fig. 2B) , these probes failed to hybridize to type B hybrid DNA (Fig. 2 A and B) . However, CF63, a marker estimated to be 100 kb downstream from the MET transcription unit (26) , is detected (Fig. 2B) . (Table 1) ] as well as cellular DNA described in Fig. 1 was digested with EcoRI, fractionated by agarose gel electrophoresis, and transferred to nylon membranes (20) . (A) The nylon filter was sequentially hybridized to the following 32P-labeled DNA probes: pJ3.11 (5) and probes from the MET transcription unit representative of the 3' end [pmet D (14) ], and the 5' Our results show that two MET alleles are rearranged in MNNG-HOS cells. The der(7) marker was present in the earliest passage of HOS cells analyzed (12) and may have been present in the original tumor; the second allele containing the TPR-MET oncogene rearrangement was generated during treatment of HOS cells in vitro with MNNG. The presence of MET 5' sequences, pJ3.11, 7C22, and B79a in type C hybrids but not in type B hybrids (Fig. 2 A and B) indicates that the der(7) could not have participated in the MNNG-mediated event that gave rise to the TPR-MET oncogene. Moreover, we have determined that the 7.2-kb MET Taq I RFLP (14, 15) is in type B hybrids and therefore on der(7) (data not shown), whereas the 5.2-kb MET Taq I RFLP is in type C hybrids and, as previously shown (14) , is associated with the TPR-MET oncogene. The TPR-MET oncogene locus expresses a novel 5-kb hybrid transcript (14) and a 65-kDa polypeptide product with tyrosine kinase activity (27) . HOS cells and their derivatives also express a 6-kb transcript that is not observed in other human cells (14) . It is possible that this transcript is expressed from the der (7) MET allele. It is not, however, detected in type B hybrids (M.P., unpublished data). (7) found in HOS and MNNG-HOS cells. Arrows beside normal chromosome 1 and 7 indicate bands involved in the translocation breakpoint of der (7). (B and C) In situ chromosome hybridization of MET using pmetl probe (15 (16, 28) , our analyses demonstrate that this chromosome cannot be used for purposes of mapping the CF mutation.
As predicted from their tight genetic linkage (29) , the sublocalization of MET to 7q31-32 is consistent with the location of 7C22 (30) as determined by in situ hybridization. This is also in agreement with our previous MET localization studies (3) and with the regional mapping of MET, pJ3.11, and 7C22 to 7q22-32 by using somatic cell hybrids (10, 31) .
The absence of the 5' end of the MET locus from der (7) suggests two possibilities. The first is that MET maps to the translocation breakpoint. The chromosomal localization of MET is consistent with it being at the breakpoint in der(7). However, in the absence of a reciprocal balanced translocation chromosome containing the deleted 5' end of MET, in situ hybridization can only localize MET to the vicinity of the breakpoint. We have, however, identified a restriction fragment that is unique to HOS, MNNG-HOS, and type B hybrid cell DNA by using a MET protooncogene probe (data not shown). This altered fragment is thus on der(7), and if it represents the breakpoint in MET [it contains sequences from the MET locus and sequences from a chromosome other than 7 (M.P., unpublished data)], then the orientation of the MET transcription unit is 7cen-3' MET 5'-7qter and the other CF markers (7C22, B79a, and pJ3.11) are upstream of MET. This would include the CF locus, since genetic linkage analyses indicate that it maps between pJ3.11 and MET (5-7). The absence of other tightly linked CF markers on der(7), representing an estimated 6 x 103 kb of genomic DNA (25, 28) , would be consistent with their location upstream to MET. However, a second possibility is that rearrangements have occurred upstream and downstream of the MET locus on der(7).We have no evidence to support the latter, but the conclusions regarding the orientation of the MET locus to the tightly linked CF markers pJ3.11, 7C22, and B79a must be tempered by this reservation.
